Oncotarget’s E-Cigarette Study

A study has been conducted by medicine man Ifran Rahman that has shed light on the unfortunate notion that e-cigarettes much like regular cigarettes are hazardous to health. Specifically it has been identified that the vapors release inflammatory proteins that are hazardous to gum tissue at a molecular level. In addition to this, the coupled flavor vapors are also hazardous to the gum tissue. When vapors are burned, the damage occurs. This is unfortunate mostly in that many people have the opinion that e-cigs are a healthy substitute to regular cigarettes when in fact it has become quite clear that they are not. Though they affect health in different ways, users are risking their well being by using either of them. They both also contain nicotine which is both addictive and another hazard that could lead to several oral diseases. Check the journal at SCImago Journal & Country Rank.

Ifran Rahman hopes that e-cig companies will start to release all the ingredients of their products to full public view so that he may uncover more possible secrets of the e-cig companies. Up to this point it seems that the companies have not been fully honest in documenting the ingredients required to produce such hazardous products. The goal of the studies conducted by Ifran Rahman are simply to educate the public more adequately on the effects of using such products being that they have been a bit ignorant to the facts up to this point. Not to the public’s discredit. As Ifran Rahman continues to study the products he hopes the companies will be more willing to share private information and better educate the public on what it is that they’re unknowingly consuming.

Oncotarget is a detailing of pathological routes of diseases, cancer studies, therapy studies, and patient management studies all coupled together in a peer to peer review. The efforts of such collections is to produce better practices in the medical industry via improved patient care as well as development of more effective treatments and management programs. The trialed evidence also goes over the effectiveness of treatments by practicing medical professionals. Visit Oncotarget’s profile page at facebook.com